Home > Drug Search >
  • company_query: Athera
  •   > 
Drug Filter
Category:
chemistry (5) biology (44)
Status:
Approved (2) NDA Filing (1) BLA Filing (1) Phase Ⅲ (5) Phase Ⅱ (23) Phase Ⅰ (17)
Clinical Stage:
Active (41) Discontinued (6)
Bio-Type:
Gene therapy (1) Cell therapy (1) CAR T cell therapy (9) Vaccine (9) Blood extraction (4) Recombinant hormone (1) Whole antibody (2) ADC (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (1) Bladder cancer (2) Breast cancer (3) Chronic lymphocytic leukemia (CLL) (2) Diabetic nephropathy (1) Transplant rejection (1) Urogenital cancer (1) Glaucoma (2) Glioblastoma multiforme (1) Cytomegalovirus infections (1) HBV infection (2) HCV infection (1) Hepatocellular carcinoma (HCC) (2) Influenza virus infection (1) Leukemia (1) Lung cancer (1) Lymphoma (1) Macular degeneration (1) Melanoma (1) Chemotherapy-induced anaemia (1) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (3) Ocular hypertension (1) Ovarian cancer (2) Pancreatic cancer (1) Prostate cancer (1) Poliomyelitis (1) Psoriasis (1) Smoking cessation (1) Solid tumours (3) Systemic lupus erythematosus (1) Thyroid cancer (1) Type 2 diabetes (3) Hodgkin lymphoma (1) Colorectal cancer (3) Neuroblastoma (2) Systemic inflammatory response syndrome (SIRS) (1) Sarcoma (2) Type 1 diabetes (1) Hematological cancer (2) Spinal cord injury (1) Sepsis (1) Hereditary inclusion body myopathy (HIBM) (1) Glioblastoma (5) Glioma (1) Immunodeficiency disorders (1) Acquired thrombotic thrombocytopenic purpura (1) Cardiovascular disorders (1) Inflammation (1) Optic neuritis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top